Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia

Clinical trial NCT00361543 · COMPLETED

Trial details

NCT number: NCT00361543
Sponsor: The Alfred
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Schizophreniform Disorder

Start date: 2006-08-01
Primary completion: 2014-12-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.